BASF Venture Capital and Orbia Ventures invest in Israeli biotech company FortePhest

Date：Feb. 11, 2022

BASF Venture Capital GmbH (BVC) and Orbia Ventures announced their Series-B investment in the Israeli biotech startup FortePhest.